Stopping finasteride: what happens to your hair, DHT, and the side effects, and what to discuss with your doctor?

Finasteride's effect is tied to taking it: after stopping, the benefit to your hair is lost over months. The summary of product characteristics for Propecia, the daily 1 mg finasteride tablet approved for hair loss (the regulator-approved technical description), puts it this way: if treatment is stopped, the beneficial effect starts to reverse by month 6, and returns to the baseline level within 9-12 months. The same text also says that continuous use is recommended to maintain the benefit.1

The summary doesn't cite a separate study for this statement, it is the regulator-approved finding. For starting treatment, the same text gives 3-6 months: that's how much daily use is needed before stabilisation of hair loss can be expected. 1 Both directions are a matter of months. How finasteride acts on the follicle, I described in the article on oral DHT blockers.

What to take from this: someone who stops loses, over roughly a year, what finasteride gave their hair.

This is why you should discuss stopping finasteride, reducing the dose, and switching to another drug with your doctor. I'm not a doctor, I'm a cosmetology student; this article collects what the regulatory texts and the trials say about it.

The active ingredient itself clears within days, the effect on hair fades over months: these are two separate timescales. Per Propecia's summary of product characteristics, finasteride's half-life, meaning the time it takes for the blood level to drop by half, is roughly 5-6 hours in men aged 18-60, and 8 hours over 70.1 A 2026 review (Roidos and colleagues), summarising treatment of enlarged prostate, states in its table that after stopping, finasteride clears within days.2

I did not find a trial that measures the return of blood DHT (dihydrotestosterone, the hormone driving male-pattern hair loss) day by day after stopping, and Propecia's summary doesn't give a figure for this either. That the drug disappears from the blood within days follows from its half-life; exactly when DHT reaches its earlier level is not measured data.

What to take from this: the drug disappears within days, but on hair, per the summary's timeline, the change comes over months.

Sexual side effects, per the trials, are infrequent, mostly mild, and in most cases resolve after stopping. Per Propecia's summary, in the 12-month, placebo-controlled trials, a drug-related sexual side effect occurred in the first year in 3.8 percent of those taking finasteride, versus 2.1 percent of those on placebo. Because of this, roughly 1 percent of men in both groups stopped taking it. Among those who continued, the rate fell to 0.6 percent over the following four years. Decreased libido, erectile dysfunction, and reduced ejaculate, per the summary, resolved in those who stopped, and in many of those who continued too.1

A 2026 systematic review (Złotowska and colleagues), which collected the sexual side effects of 5-alpha-reductase inhibitors (drugs that block DHT formation) used for hair loss, states that most complaints reported in controlled trials are infrequent, mild, and resolve after stopping, though individual sensitivity varies.3 Rarely, a sexual complaint persisting even after stopping has also been reported, Propecia's summary lists this too; it is called post-finasteride syndrome (PFS), and I cover it in a separate article.1

The full list and frequency of side effects is in the article on finasteride side effects. What to take from this: a minority of men stopped because of a side effect, and the complaints mostly resolve; if this happened to you, it's worth discussing stopping and the other options with your doctor too.

For one situation, the regulator specifically states that the tablet must be stopped: if low mood, depression, or suicidal thoughts occur. After the European Medicines Agency's (EMA) 2025 EU-wide review, the Hungarian regulator (NNGYK) and the manufacturers informed doctors by letter: the EMA confirmed that suicidal thoughts are a side effect linked to daily 1 mg finasteride, with an unknown frequency. The letter asks doctors to tell patients taking the tablet for hair loss: if they experience this symptom, stop treatment and see a doctor.5 If this happens to you, don't wait for your next check-up.

In every other case, the timing and manner of stopping is a question to discuss with your doctor: for a side effect, before planning a child, or if you switch to another drug. On planning a child, this much belongs here: per Propecia's summary, post-marketing reports have described cases where sperm quality normalised or improved after stopping.1 I've collected the details in the article on finasteride and planning a child.

I did not find a trial on gradual discontinuation for hair loss, for example every-other-day dosing. We searched the Europe PMC scientific database specifically, and not a single publication came up that measured a reduced or spaced-out finasteride dosing schedule for hair loss. Propecia's summary specifies once-daily dosing, and recommends continuous use to maintain the benefit.1

This means tapering off finasteride is not a studied method: it's not known whether it would reduce side effects, or whether it would slow the loss of the effect. Ask your doctor this: does gradual discontinuation have any advantage over simply stopping, in your situation?

I did not find a trial measuring switching to the branded finasteride spray; there is a small, uncontrolled body of evidence on switching to dutasteride or a compounded topical mix, and none of it measures how long the two drugs' effects overlap, or how the side effects wind down in between. Chandrashekar and colleagues, in 2015, retrospectively reviewed the charts and photos of 50 men: after two years of oral finasteride and 5 percent minoxidil, the tablet was switched to a 0.1 percent finasteride compounded into a 5 percent minoxidil solution. This mix is not the branded spray. Of the 50 men, 45 switched without interruption; among them, seven showed a mild decrease, 13 showed no decrease, in fact hair density improved, and in the rest, according to the authors, it first decreased slightly after the switch and then plateaued. Five had taken nothing at all for 8-12 months beforehand, and only then started the mix. There was no control group, and minoxidil continued throughout, so the two drugs' effects cannot be separated.6 Jung and colleagues, in 2014, switched 35 men who had shown no meaningful improvement on finasteride for at least six months to daily 0.5 mg dutasteride; this too was not a controlled trial, and six of the 35 men reported a transient sexual complaint.7

Beyond this, the two target drugs' own data are known. The scalp-sprayed finasteride spray, in its registration trial (Piraccini and colleagues, 2022), reduced blood DHT by an average of 34.5 percent at week 24, versus 55.6 percent for the daily 1 mg tablet.4 Anyone switching from a tablet to the spray should expect a smaller DHT reduction in the blood; what this means for hair at the time of switching hasn't been measured. Details on the spray are in the article on topical finasteride.

Dutasteride is the other direction. The Roidos review's table gives its half-life as roughly 5 weeks, and says it takes several months to clear after stopping; according to the authors, this long half-life can prolong the side effects after stopping. This review is about enlarged prostate, where finasteride's dose is daily 5 mg; the active ingredient is the same.2 I wrote more about dutasteride in the article on DHT blockers and on dutasteride mesotherapy.

What to take from this: with dutasteride, the wind-down is measured in months, with finasteride, in days. If you're switching to either, ask your doctor this: how long do the two drugs' effects overlap, and what should you watch for in the meantime?

Before stopping, it's worth going through these with your doctor.

• What's my reason for wanting to stop: a side effect, planning a child, cost, or something else?
• If it's a side effect, is there another cause worth investigating?
• Is there a drug I could switch to, and what should I watch for when switching?
• How will we track the change in my hair over the next year?
• If I started again later, what should I expect?

Microneedling is a mechanical stimulus with no hormonal effect, so it can be used alongside medications that act on DHT. Dermastamp is a fixed 1 mm, at-home device: the needle stimulates the area around the follicle, and its mechanism doesn't touch DHT. This is inferred from the mechanism, not measured. You don't skip oral finasteride or dutasteride on the day of stamping. With scalp-applied products, the day of stamping is a pause, and the exact timing differs by product: the timing of actives. For anyone who'd rather not touch their hormones, this is a route that stays open, with one limitation: in the study measuring the combination, both groups also received minoxidil, and the study used a 1.5 mm clinical roller, not our fixed 1 mm device; there's less data for standalone use. What it can do, what it can't, and who it's not for: I've written it all on its page.

See Dermastamp